Yi-Qiang (Eric) Cheng
Assistant Professor
Biological Sciences, UWM

Phone: (414) 229-4739
Fax: (414) 229-3926
E-Mail:
Web Site: Biological Sciences Page

University of Wisconsin-Milwaukee
Lapham Hall, 131C

Research Interests

My lab is designed to develop new methodology and technology for the discovery and engineering of pharmaceutically relevant microbial natural products as drugs or drug leads. Initial research will focus on:

    1) The study of molecular genetics of homologous DNA recombination processes in actinomycetes, to develop a set of tools and methodology for the improvement of homologous DNA recombination frequency in actinomycetes for engineered biosynthesis of novel drug analogs;

    2) Microbial biodiversity in the Great Lakes. Natural product biosynthesis and drug discovery in marine and freshwater microorganisms;

    3) The development of computational algorithms to survey microbial genome sequence data for the prediction of metabolic potential.

The long-term goal is to apply the methodology and technology obtained from the pilot studies for large-scale discovery and development of human and veterinary medicines.

See Dept of Biology Page for more information.

Education
•  
Ph.D., Michigan State University, 1999
•  
PDF, University of California - Davis, 1999-2001
•  
PDF, University of Wisconsin - Madison, 2001-2003
Selected Publications
•  
Tang, G.-L*., Cheng, Y.-Q*. and B. Shen. (2004) The biosynthetic gene cluster of the antitumor antibiotic leinamycin from Streptomyces atroolivaceus S-140 revealing unprecedented architectural complexity for a hybrid polyketide synthase and nonribosomal peptide synthetase. Chem. & Biol. 11:33-45.
•  
Cheng, Y.-Q*. Tang, G.-L* and B. Shen. (2003) Type I polyketide synthase requiring a discrete acyltransferase for polyketide biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 100:3149-3154 (Highlighted by a Commentary).
•  
Cheng, Y.-Q. Tang, G.-L. and B. Shen. (2002) Identification and localization of the antitumor macrolactam leinamycin biosynthesis gene cluster from Streptomyces atroolivaceous S-140. J. Bacteriol. 184:7013-7024.
•  
Ahn, J.-H., Cheng, Y.-Q. and Walton, J. D. (2002) A refined physical map of the TOX2 locus of Cochliobolus carbonum required for cyclic peptide biosynthesis. Fungal Genet. Biol. 35:31-38.
•  
Cheng, Y.-Q. and Walton J. D. (2000) A eukaryotic alanine racemase gene involved in cyclic peptide biosynthesis. J. Biol. Chem. 275, 4906-4911.
•  
Cheng, Y.-Q., Ahn, J.-H. and Walton J. D. (1999) A putative branched-chain-amino-acid transaminase gene required for HC-toxin biosynthesis and pathogenicity in Cochliobolus carbonum. Microbiology 145, 3539-3546.
•  
Cheng, Y.-Q., Le, L. D., Walton, J. D. and Bishop, K. D. (1999) 13C labeling indicates that the epoxide-containing amino acid of HC-toxin is synthesized by head-to-tail condensation of acetate. J. Nat. Prod. 62, 143-145.
•  
Scott-Craig, J., Cheng, Y.-Q., Cervone, F., de Lorenzo, G., Pitkin, J. W. and Walton, J. D. (1998) Targeted mutants of Cochliobolus carbonum lacking the two major extracellular polygalacturonases. Appl. Environ. Microbiol. 64, 1497-1503.